Literature DB >> 17297602

The dilemma of the late-onset "dystrophy".

Michael F Marmor1.   

Abstract

A case of late-onset (age 51) visual loss and night-blindness is presented to illustrate the challenges of diagnosis. This patient had anti-enolase antibodies, and demonstrates the importance of auto-immune retinopathy as a potential cause of late-onset retinal "dystrophy."

Entities:  

Mesh：

Year:  2007        PMID： 17297602     DOI： 10.1007/s10633-007-9046-0

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN： 0012-4486            Impact factor:   2.379


  7 in total

1.  Guidelines for basic multifocal electroretinography (mfERG).

Authors:  Michael F Marmor; Donald C Hood; David Keating; Mineo Kondo; Mathias W Seeliger; Yozo Miyake
Journal:  Doc Ophthalmol       Date:  2003-03       Impact factor: 2.379

2.  Standard for clinical electroretinography (2004 update).

Authors:  Michael F Marmor; Graham E Holder; Mathias W Seeliger; Shuichi Yamamoto
Journal:  Doc Ophthalmol       Date:  2004-03       Impact factor: 2.379

3.  Clinical and genetic heterogeneity in retinitis pigmentosa.

Authors:  J Kaplan; D Bonneau; J Frézal; A Munnich; J L Dufier
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

Review 4.  Progressive cone and cone-rod dystrophies: phenotypes and underlying molecular genetic basis.

Authors:  Michel Michaelides; Alison J Hardcastle; David M Hunt; Anthony T Moore
Journal:  Surv Ophthalmol       Date:  2006 May-Jun       Impact factor: 6.048

5.  Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.

Authors:  Richard G Weleber; Robert C Watzke; William T Shults; Karmen M Trzupek; John R Heckenlively; Robert A Egan; Grazyna Adamus
Journal:  Am J Ophthalmol       Date:  2005-05       Impact factor: 5.258

6.  Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.

Authors:  S M Whitcup; B P Vistica; A H Milam; R B Nussenblatt; I Gery
Journal:  Am J Ophthalmol       Date:  1998-08       Impact factor: 5.258

7.  Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.

Authors:  Grazyna Adamus; Gaoying Ren; Richard G Weleber
Journal:  BMC Ophthalmol       Date:  2004-06-04       Impact factor: 2.209
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.